The E-Rezept TestSuite is divided into several parts and is intended to cover the upper part of the test pyramid.
See ReleaseNotes.md for all information regarding the (newest) releases.
To get started with the test suite, it is important to understand the architecture of the testsuites and their core modules:
Primarily serves as a test data generator to assist in manual/exploratory testing of the e-prescription.
For further information, please see the full documentation
Is the end-to-end test suite and focuses mainly on acceptance tests.
These test scenarios are described with the description language Gherkin. The feature-files describing the test scenarios are located at primsys-bdd/src/test/resources/features
For further information, please see the full documentation
The "product testsuite" is focused on system testing and the coverage of specific requirements.
The test cases are utilising JUnit5 and are located at erp-fd-product-test/src/integration-test
For further information, please see the full documentation
This testsuite focuses the end-to-end integration with the E-Rezept-App-iOS by using Appium.
The feature-files describing these test scenarios are located at erp-app-bdd/src/test/resources/features
For further information, please see the full documentation
To be able to build testsuites, make sure you have all the following required prerequisites on your development machine:
- Java 17 and Maven
In order to be able to run the testsuites, you must also ensure that the following prerequisites are met on your development computer
- Reachability of the TI
- Authorization1
Because this information1 is very sensitive and must be authorized per user, it is not publicly available here. Within, e.g., the configuration files; you can easily identify these fields:
environments:
- name: TU
tslBaseUrl: https://download-ref.tsl.ti-dienste.de/ECC/
ti:
discoveryDocumentUrl: https://...
fdBaseUrl: https://...
subscriptionServiceUrl: wss://...
userAgent: DUMMY VALUE # <-- not public
internet:
discoveryDocumentUrl: https://...
fdBaseUrl: https://...
xapiKey: DUMMY VALUE # <-- not public
userAgent: DUMMY VALUE # <-- not publicIf you are interested in running testsuite, please use the contact options below.
All modules and consequently the whole project can be built using maven
mvn clean install -DskipTests
or just to run the unit tests
mvn clean test
To execute the testsuites, maven is used as well:
Run the E2E Testsuite
mvn -f primsys-bdd/pom.xml clean verify -Dskip.unittests
respectively, run the System Testsuite
mvn -f erp-fd-product-test/pom.xml clean verify -Dskip.unittests
respectively, run the App Testsuite
mvn -f erp-app-bdd/pom.xml clean verify -Dskip.unittests
For further information on executing the testsuites, please see the full documentation
If you want to contribute, please check our CONTRIBUTING.md.
Copyright 2025 gematik GmbH
Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License.
See the LICENSE for the specific language governing permissions and limitations under the License.
Unless required by applicable law the software is provided "as is" without warranty of any kind, either express or implied, including, but not limited to, the warranties of fitness for a particular purpose, merchantability, and/or non-infringement. The authors or copyright holders shall not be liable in any manner whatsoever for any damages or other claims arising from, out of or in connection with the software or the use or other dealings with the software, whether in an action of contract, tort, or otherwise.
The software is the result of research and development activities, therefore not necessarily quality assured and without the character of a liable product. For this reason, gematik does not provide any support or other user assistance (unless otherwise stated in individual cases and without justification of a legal obligation). Furthermore, there is no claim to further development and adaptation of the results to a more current state of the art.
Gematik may remove published results temporarily or permanently from the place of publication at any time without prior notice or justification.
- Copyright notice: Each published work result is accompanied by an explicit statement of the license conditions for use. These are regularly typical conditions in connection with open source or free software. Programs described/provided/linked here are free software, unless otherwise stated.
- Permission notice: Permission is hereby granted, free of charge, to any person obtaining a copy of this software and associated documentation files (the "Software"), to deal in the Software without restriction, including without limitation the rights to use, copy, modify, merge, publish, distribute, sublicense, and/or sell copies of the Software, and to permit persons to whom the Software is furnished to do so, subject to the following conditions:
- The copyright notice (Item 1) and the permission notice (Item 2) shall be included in all copies or substantial portions of the Software.
- The software is provided "as is" without warranty of any kind, either express or implied, including, but not limited to, the warranties of fitness for a particular purpose, merchantability, and/or non-infringement. The authors or copyright holders shall not be liable in any manner whatsoever for any damages or other claims arising from, out of or in connection with the software or the use or other dealings with the software, whether in an action of contract, tort, or otherwise.
- The software is the result of research and development activities, therefore not necessarily quality assured and without the character of a liable product. For this reason, gematik does not provide any support or other user assistance (unless otherwise stated in individual cases and without justification of a legal obligation). Furthermore, there is no claim to further development and adaptation of the results to a more current state of the art.
- Gematik may remove published results temporarily or permanently from the place of publication at any time without prior notice or justification.
- Please note: Parts of this code may have been generated using AI-supported technology. Please take this into account, especially when troubleshooting, for security analyses and possible adjustments.
E-Mail to Medical Entwicklung

